Candriam SCA’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-96,619
| Closed | -$7.95M | – | 681 |
|
|
2023
Q2 | $7.95M | Sell |
96,619
-21,895
| -18% | -$1.8M | 0.06% | 274 |
|
|
2023
Q1 | $11.2M | Buy |
118,514
+10,800
| +10% | +$1.02M | 0.08% | 243 |
|
|
2022
Q4 | $15.8M | Buy |
107,714
+7,800
| +8% | +$1.14M | 0.11% | 197 |
|
|
2022
Q3 | $16.9M | Buy |
99,914
+20,292
| +25% | +$3.43M | 0.12% | 187 |
|
|
2022
Q2 | $9.2M | Buy |
79,622
+5,829
| +8% | +$673K | 0.08% | 237 |
|
|
2022
Q1 | $7.36M | Sell |
73,793
-7,123
| -9% | -$710K | 0.05% | 295 |
|
|
2021
Q4 | $12.6M | Hold |
80,916
| – | – | 0.08% | 231 |
|
|
2021
Q3 | $19.1M | Buy |
80,916
+2,000
| +3% | +$471K | 0.13% | 183 |
|
|
2021
Q2 | $26.8M | Buy |
78,916
+34,029
| +76% | +$11.6M | 0.18% | 131 |
|
|
2021
Q1 | $28.7M | Buy |
44,887
+1
| +0% | +$639 | 0.24% | 110 |
|
|
2020
Q4 | $29.9M | Buy |
44,886
+21,378
| +91% | +$14.2M | 0.24% | 110 |
|
|
2020
Q3 | $10.9M | Sell |
23,508
-322
| -1% | -$150K | 0.1% | 215 |
|
|
2020
Q2 | $13.9M | Buy |
+23,830
| New | +$13.9M | 0.15% | 166 |
|
|
2018
Q2 | – | Sell |
-1,440
| Closed | -$568K | – | 814 |
|
|
2018
Q1 | $568K | Buy |
1,440
+960
| +200% | +$379K | 0.01% | 662 |
|
|
2017
Q4 | $197K | Buy |
+480
| New | +$197K | ﹤0.01% | 742 |
|